Immutep - ADR Peer Comparison

$0.37

$-0.01 (-2.78%)

As on 31-Aug-2026 13:31EDT

Market cap

$56 Mln

Revenue (TTM)

$4 Mln

P/E Ratio

--

P/B Ratio

0.8

Div. Yield

0 %

Edit

	Immutep - ADR	Zai Lab - ADR	Mesoblast - ADR	HUTCHMED (China) - ADR	Galapagos NV - ADR
Market cap ($ Mln)	56	2,928	2,262	2,152	1,862
Revenue ($ Mln)	5	450	120	549	1,044
Net Profit ($ Mln)	-61.43	-188.21	-57.50	17.88	488.78
Net Margin (%)	-1,030.32	-41.86	-144.33	3.26	46.83
RoE (%)	-36.88	-28.46	-9.86	1.43	15.95
Price to Earnings	--	--	--	123.80	3.18
Price-To-Book	0.80	4.96	4.15	1.71	0.49

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Immutep - ADR	Zai Lab - ADR	Mesoblast - ADR	HUTCHMED (China) - ADR	Galapagos NV - ADR
Operating Revenue	5.04	460.16	17.20	549.96	1,112.25
Cost of Revenue	61.41	191.08	5.13	337.24	29.74
Gross Profit	-56.37	269.08	12.07	212.72	1,082.51
Operating Expenses	70.06	492.65	74.51	267.45	581.12
Operating Profit (EBIT)	-126.42	-223.57	-62.44	-54.73	501.39
Other Income	--	--	--	--	--
Profit before Tax	-61.43	-178.46	-101.81	522.72	300.87
Provision for Tax	--	-2.93	0.33	63.78	-18.62
Profit after Tax (Net Income)	-61.43	-175.54	-102.14	458.12	320.88
Minority Interest	--	--	--	--	--
Consolidated Profit	--	--	--	--	--

Liabilities ($ Mln)

	Immutep - ADR	Zai Lab - ADR	Mesoblast - ADR	HUTCHMED (China) - ADR	Galapagos NV - ADR
Shareholder's Funds	143.64	715.50	597.44	1,237.93	3,234.49
Minority Interest	--	--	--	--	--
Non-Current Liabilities	0.59	40.72	84.62	186.06	17.78
Current Liabilities	12.76	416.17	102.63	315.78	152.80
Total Liabilities	156.98	1,172.38	784.68	1,753.10	3,405.07

Assets ($ Mln)

	Immutep - ADR	Zai Lab - ADR	Mesoblast - ADR	HUTCHMED (China) - ADR	Galapagos NV - ADR
Non-Current Assets	7.89	153.10	580.33	185.76	326.92
Current Assets	149.10	1,019.29	204.35	1,567.35	3,078.15
Total Assets	156.98	1,172.38	784.68	1,753.10	3,405.07
Total Debt*	1.63	224.26	128.16	97.89	6.92
Net Current Assets	--	603.12	101.72	1,251.57	2,926.59

Cashflow ($ Mln)

	Immutep - ADR	Zai Lab - ADR	Mesoblast - ADR	HUTCHMED (China) - ADR	Galapagos NV - ADR
Cash From Operating Activities	-62.05	-150.79	-49.95	-64.66	-189.23
Cash Flow from Investing Activities	-38.53	307.87	0.12	-29.41	219.35
Cash from Financing Activities	-0.53	72.35	147.34	7.84	-3.14
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Immutep - ADR	Zai Lab - ADR	Mesoblast - ADR	HUTCHMED (China) - ADR	Galapagos NV - ADR
ROCE (%)	-36.53	-18.15	-15.42	41.92	10.44
ROE (%)	-36.88	-22.56	-18.95	45.86	10.47
ROA (%)	-34.27	-14.89	-14.05	30.27	8.51
EBIT Margin (%)	--	--	--	--	--
Net Margin (%)	-1,218.02	-38.15	-593.92	83.30	28.85
Cash Profit Margin (%)	--	--	--	--	--

Growth Ratios

	Immutep - ADR	Zai Lab - ADR	Mesoblast - ADR	HUTCHMED (China) - ADR	Galapagos NV - ADR
Revenue Growth (%)	0.31	0.15	1.91	-0.13	3.04
EBIT Growth (%)	--	--	--	--	--
Net Profit Growth (%)	-43.82	31.73	-16.13	1,114.23	333.15
EPS Growth (%)	-0.20	0.37	-0.02	11.14	3.39
Book Value Growth (%)	--	--	--	--	--

Valuation Ratios

	Immutep - ADR	Zai Lab - ADR	Mesoblast - ADR	HUTCHMED (China) - ADR	Galapagos NV - ADR
Price / Earnings	-3.89	-11.11	-13.58	5.08	6.71
Price / Book Value	1.67	2.73	2.32	1.88	0.67
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-1.77	-9.39	-18.38	-25.58	-2.33
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Immutep - ADR	Zai Lab - ADR	Mesoblast - ADR	HUTCHMED (China) - ADR	Galapagos NV - ADR
Debt to Equity	0.01	0.31	0.21	0.08	0.00
Short term debt to equity ratio	0.01	0.29	0.10	0.02	0.00
Current Ratio	11.69	2.45	1.99	4.96	20.15
Quick Ratio	--	2.27	1.77	4.83	20.00
Interest Coverage	-2,707.45	-33.26	-3.49	-19.05	136.71

Operating Efficiency Ratios

	Immutep - ADR	Zai Lab - ADR	Mesoblast - ADR	HUTCHMED (China) - ADR	Galapagos NV - ADR
Debtors to sales (%)	0.15	23.06	86.44	26.88	4.78
Asset Turnover	0.03	0.39	0.02	0.36	0.29
Receivable days	273.95	77.60	380.35	104.79	16.53
Inventory Days	11.33	109.55	791.94	49.57	452.54
Payable days	27.73	231.78	931.00	47.68	1,242.94
Cash Conversion Cycle	257.55	-44.63	241.30	106.67	-773.87

Annual
Quarterly